Mirae Asset Global ETFs Holdings’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106K Sell
2,212
-7,301
-77% -$314K ﹤0.01% 2799
2026
Q1
$350K Buy
9,513
+918
+11% +$43.5K ﹤0.01% 2069
2025
Q4
$437K Buy
8,595
+2,662
+45% +$136K ﹤0.01% 1954
2025
Q3
$329K Sell
5,933
-94,945
-94% -$5.56M ﹤0.01% 2066
2025
Q2
$6.96M Buy
100,878
+4,391
+5% +$299K 0.01% 668
2025
Q1
$6.7M Buy
96,487
+1,407
+1% +$116K 0.01% 679
2024
Q4
$8.18M Buy
95,080
+2,920
+3% +$316K 0.02% 626
2024
Q3
$11M Buy
92,160
+5,482
+6% +$731K 0.02% 525
2024
Q2
$12.4M Buy
+86,678
New +$11.5M 0.03% 478

Other funds holding NVO

Mirae Asset Global ETFs Holdings's NVO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Novo Nordisk (NVO) stake by 77% in Q2 2026, selling an estimated $314K and leaving 2,212 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #2799.

Mirae Asset Global ETFs Holdings first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.4M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 2,212 shares of Novo Nordisk worth $106K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 7,301 Novo Nordisk shares in Q2 2026, an estimated $314K.
  • Novo Nordisk made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2799 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Novo Nordisk position peaked at $12.4M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.